Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
SeaSpine Holdings Corporation is a medical devices business based in the US. SeaSpine Holdings Corporation shares (SPNE) are listed on the NASDAQ and all prices are listed in US Dollars. SeaSpine Holdings Corporation employs 386 staff and has a trailing 12-month revenue of around USD$151.6 million.
|52-week range||USD$4.02 - USD$19.81|
|50-day moving average||USD$17.2638|
|200-day moving average||USD$15.229|
|Wall St. target price||USD$20.78|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-2.273|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Revenue TTM||USD$151.6 million|
|Gross profit TTM||USD$101.1 million|
|Return on assets TTM||-13.51%|
|Return on equity TTM||-28.15%|
|Market capitalisation||USD$532.5 million|
TTM: trailing 12 months
There are currently 523,306 SeaSpine Holdings Corporation shares held short by investors – that's known as SeaSpine Holdings Corporation's "short interest". This figure is 10.3% down from 583,487 last month.
There are a few different ways that this level of interest in shorting SeaSpine Holdings Corporation shares can be evaluated.
SeaSpine Holdings Corporation's "short interest ratio" (SIR) is the quantity of SeaSpine Holdings Corporation shares currently shorted divided by the average quantity of SeaSpine Holdings Corporation shares traded daily (recently around 118127.76523702). SeaSpine Holdings Corporation's SIR currently stands at 4.43. In other words for every 100,000 SeaSpine Holdings Corporation shares traded daily on the market, roughly 4430 shares are currently held short.
However SeaSpine Holdings Corporation's short interest can also be evaluated against the total number of SeaSpine Holdings Corporation shares, or, against the total number of tradable SeaSpine Holdings Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case SeaSpine Holdings Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 SeaSpine Holdings Corporation shares in existence, roughly 20 shares are currently held short) or 0.0239% of the tradable shares (for every 100,000 tradable SeaSpine Holdings Corporation shares, roughly 24 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against SeaSpine Holdings Corporation.
Find out more about how you can short SeaSpine Holdings Corporation stock.
We're not expecting SeaSpine Holdings Corporation to pay a dividend over the next 12 months.
Over the last 12 months, SeaSpine Holdings Corporation's shares have ranged in value from as little as $4.02 up to $19.81. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while SeaSpine Holdings Corporation's is 1.191. This would suggest that SeaSpine Holdings Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products include demineralized bone matrices (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. The company also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. Its spinal implant portfolio comprises products for spinal decompression, alignment, and stabilization that are used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. The company has development and licensing agreement with restor3d, Inc. to develop 3D-printed interbody devices. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.